Diabetes
News
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
News
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
Clinical
In-hospital glucose management program gives dramatic savings
“I’ve been advocating for endocrine hospitalists to be deployed nationally,” said Dr. Misha Zilbermint.
News
Most kids with type 1 diabetes and COVID-19 in U.S. fared well
News
High obesity rates in Southern states magnify COVID threats
At least 29 states have green-lighted obesity for inclusion in the first phases of the COVID-19 vaccine rollout. That could overwhelm government...
News
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured...
News
Heart failure redefined with new classifications, staging
News
Thirteen percent of patients with type 2 diabetes have major ECG abnormalities
ECGs from more than 8,000 Dutch patients with type 2 diabetes, most without known cardiovascular disease, show that major abnormalities are not...
News
More from DAPA-HF: Dapagliflozin quickly reduces heart failure events
Clinical
Quick byte: Curing diabetes
“If it works in people as well as it does in animals, it’s possible that people will not be diabetic.”